- Email: [email protected]
2013 Research Awards
2013 Research Awards SIR Foundation is a scientific foundation dedicated to fostering research in interventional radiology for the purposes of advancing scientific knowledge, increasing the number of skilled investigators and developing innovative therapies that lead to improved patient care and quality of life. The Foundation is committed to developing and enhancing innovative, minimally invasive, image-guided therapies from inception to mature clinical application and to conducting educational programs in the service of its mission. Each year SIR Foundation proudly supports award programs that recognize outstanding achievements in research and innovation. The 2013 research awards will be presented on Monday, April 15, during the “Quality in IR” plenary session at 10:00 am in the Auditorium.
Dr. Constantin Cope Medical Student Research Award n High-field MRI Accurately Quantifies Tumor Uptake of Therapeutic Iron Oxide Nanoparticles in McSRH7777 Rat Model of Liver Cancer. (Oral Presentation Abstract #191 to be presented Wednesday, April 17, at 8:48–9:56 am. Room 289.)—Patrick Tyler, Feinberg School of Medicine, Northwestern University, Chicago, Ill. n Transcatheter Intra-arterial delivery of Superparamagnetic Iron-oxide-labeled Natural Kill Lymphocytes to Hepatocellular Carcinoma: Longitudinal Efficacy Studies in a Rat Model. (Oral Presentation Abstract #232 to be presented Tuesday, April 16, at 2:45–2:55 pm. Room 265-268.)— Alexander Sheu, Feinberg School of Medicine, Northwestern University, Chicago, Ill. n Neuroprotective Effects of Dodecafluoropentane Emulsion in an Angiographic Model of Acute Ischemic Stroke in Rabbits. (Oral Presentation Abstract #92 to be presented Monday, April 15, at 1:30–1:38 pm. Room 289.)—Sean Woods, University of Arkansas for Medical Sciences, Little Rock, Ark. n Alginate Microspheres with Magnetically Triggered Gemcitabine Release. (Oral Presentation Abstract #187 to be presented Wednesday, April 17, at 8:16–8:24 am. Room 289.)—Terence Choy, Feinberg School of Medicine, Northwestern University, Chicago, Ill. n Transarterial Sorafenib Chemoembolization: Preliminary Study of Technical Feasibility in a Rabbit Model. (Oral Presentation Abstract #186 to be presented Wednesday, April 17, at 8:08–8:16 am. Room 289.)— Ahmad Parvinian, University of Illinois at Chicago College of Medicine, Chicago, Ill. n Biodegradable Starch Nanoparticles Are a Novel and Potentially Effective and Safe Adjuvant for Sonothrombolysis Especially for More Fibrin-rich, Aged and Rigid Clots. (Oral Presentation Abstract #95 to be presented Monday, April 15, at 1:54–2:02 pm. Room 289.)—Kaleb Smithson, University of Central Arkansas, Conway, Ark.
Dr. Constantin Cope Medical Student Research Award n High-field MRI Accurately Quantifies Tumor Uptake of Therapeutic Iron Oxide Nanoparticles in McSRH7777 Rat Model of Liver Cancer. (Oral Presentation Abstract #191 to be presented Wednesday, April 17, at 8:48–9:56 am. Room 289.)—Patrick Tyler, Feinberg School of Medicine, Northwestern University, Chicago, Ill. n Transcatheter Intra-arterial delivery of Superparamagnetic Iron-oxide-labeled Natural Kill Lymphocytes to Hepatocellular Carcinoma: Longitudinal Efficacy Studies in a Rat Model. (Oral Presentation Abstract #232 to be presented Tuesday, April 16, at 2:45–2:55 pm. Room 265-268.)— Alexander Sheu, Feinberg School of Medicine, Northwestern University, Chicago, Ill. n Neuroprotective Effects of Dodecafluoropentane Emulsion in an Angiographic Model of Acute Ischemic Stroke in Rabbits. (Oral Presentation Abstract #92 to be presented Monday, April 15, at 1:30–1:38 pm. Room 289.)—Sean Woods, University of Arkansas for Medical Sciences, Little Rock, Ark. n Alginate Microspheres with Magnetically Triggered Gemcitabine Release. (Oral Presentation Abstract #187 to be presented Wednesday, April 17, at 8:16–8:24 am. Room 289.)—Terence Choy, Feinberg School of Medicine, Northwestern University, Chicago, Ill. n Transarterial Sorafenib Chemoembolization: Preliminary Study of Technical Feasibility in a Rabbit Model. (Oral Presentation Abstract #186 to be presented Wednesday, April 17, at 8:08–8:16 am. Room 289.)— Ahmad Parvinian, University of Illinois at Chicago College of Medicine, Chicago, Ill. n Biodegradable Starch Nanoparticles Are a Novel and Potentially Effective and Safe Adjuvant for Sonothrombolysis Especially for More Fibrin-rich, Aged and Rigid Clots. (Oral Presentation Abstract #95 to be presented Monday, April 15, at 1:54–2:02 pm. Room 289.)—Kaleb Smithson, University of Central Arkansas, Conway, Ark.